Literature DB >> 6726634

Excretion, distribution, and metabolism of primaquine in rats.

A M Clark, J K Baker, J D McChesney.   

Abstract

The metabolism of the 8-aminoquinoline antimalarial drug, primaquine (I) was studied using rats. The drug was administered intravenously, intraperitoneally, and orally, and blood samples were collected at various time intervals. Primaquine was metabolized by oxidative deamination to give 8-(3-carboxy-l- methylpropylamino )-6- methoxyquinoline (III). The plasma levels of both primaquine and its metabolite were determined by HPLC. The tissue distributions of radioactive primaquine after intravenous, intraperitoneal, and oral administrations were also determined. Significant concentrations of radioactivity were found in the lungs, adrenal glands, and liver. In addition, a significant portion of the dose was found to be excreted in the feces within 24 h after administration of the drug by either of the three routes.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6726634     DOI: 10.1002/jps.2600730418

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  10 in total

1.  Selective toxicity of the antimalarial primaquine-evidence for both uncoupling and inhibitory effects of a metabolite on the energetics of mitochondria and its ATP synthase complex.

Authors:  J K Baker; J M Hullihen; P L Pedersen
Journal:  Pharm Res       Date:  1986-10       Impact factor: 4.200

2.  Receptor-mediated hepatocyte-targeted delivery of primaquine phosphate nanocarboplex using a carbohydrate ligand.

Authors:  Vishvesh M Joshi; Padma V Devarajan
Journal:  Drug Deliv Transl Res       Date:  2014-08       Impact factor: 4.617

3.  Dipeptide derivatives of primaquine as transmission-blocking antimalarials: effect of aliphatic side-chain acylation on the gametocytocidal activity and on the formation of carboxyprimaquine in rat liver homogenates.

Authors:  M J Portela; R Moreira; E Valente; L Constantino; J Iley; J Pinto; R Rosa; P Cravo; V E do Rosário
Journal:  Pharm Res       Date:  1999-06       Impact factor: 4.200

4.  Clindamycin and primaquine as primary treatment for mild and moderately severe Pneumocystis carinii pneumonia in patients with AIDS.

Authors:  J R Black; J Feinberg; R L Murphy; R J Fass; J Carey; F R Sattler
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1991-03       Impact factor: 3.267

5.  Synthesis, antimalarial, antileishmanial, antimicrobial, cytotoxicity, and methemoglobin (MetHB) formation activities of new 8-quinolinamines.

Authors:  Sanjay R Patel; Premanand Patil; Kirandeep Kaur; Meenakshi Jain; Shabana I Khan; Melissa R Jacob; Babu L Tekwani; Rahul Jain
Journal:  Bioorg Med Chem       Date:  2006-10-20       Impact factor: 3.641

6.  The pharmacokinetics of primaquine in calves after subcutaneous and intravenous administration.

Authors:  H Yoshimura; Y S Endoh; Y Ishihara; S Nakamura; Y Inoue
Journal:  Vet Res Commun       Date:  1993       Impact factor: 2.459

7.  Effect of aliphatic side-chain substituents on the antimalarial activity and on the metabolism of primaquine studied using mitochondria and microsome preparations.

Authors:  J K Baker; R H Yarber; N P Nanayakkara; J D McChesney; F Homo; I Landau
Journal:  Pharm Res       Date:  1990-01       Impact factor: 4.200

8.  Scalable preparation and differential pharmacologic and toxicologic profiles of primaquine enantiomers.

Authors:  N P Dhammika Nanayakkara; Babu L Tekwani; H M T Bandara Herath; Rajnish Sahu; Montip Gettayacamin; Anchalee Tungtaeng; Yvonne van Gessel; Paul Baresel; Kristina S Wickham; Marilyn S Bartlett; Frank R Fronczek; Victor Melendez; Colin Ohrt; Gregory A Reichard; James D McChesney; Rosemary Rochford; Larry A Walker
Journal:  Antimicrob Agents Chemother       Date:  2014-06-09       Impact factor: 5.191

9.  Excretion of metabolites in bile following the administration of primaquine to rats.

Authors:  J K Baker; J D McChesney; L A Walker
Journal:  Pharm Res       Date:  1985-09       Impact factor: 4.200

10.  Synthesis, Biological Activity and In Silico Pharmacokinetic Prediction of a New 2-Thioxo-Imidazoldidin-4-One of Primaquine.

Authors:  Mariana Pereira; Guy Caljon; Maria João Gouveia; Louis Maes; Nuno Vale
Journal:  Pharmaceuticals (Basel)       Date:  2021-02-27
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.